PRTT Stock Overview
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Protect Pharmaceutical Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$2.30 |
52 Week High | US$3.10 |
52 Week Low | US$0.20 |
Beta | 0 |
1 Month Change | -9.45% |
3 Month Change | -9.80% |
1 Year Change | 159.04% |
3 Year Change | 53.33% |
5 Year Change | 76.92% |
Change since IPO | -88.50% |
Recent News & Updates
Recent updates
Shareholder Returns
PRTT | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 3.6% | -0.2% | 0.6% |
1Y | 159.0% | 23.9% | 29.5% |
Return vs Industry: PRTT exceeded the US Pharmaceuticals industry which returned 23.1% over the past year.
Return vs Market: PRTT exceeded the US Market which returned 29.8% over the past year.
Price Volatility
PRTT volatility | |
---|---|
PRTT Average Weekly Movement | 14.0% |
Pharmaceuticals Industry Average Movement | 9.5% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PRTT's share price has been volatile over the past 3 months.
Volatility Over Time: PRTT's weekly volatility has decreased from 21% to 14% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | n/a | Alan Crooks | https://agropharmacy.com |
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hectares of forests, 6 mineral and freshwater wells, and 3000 square meters of built properties.
Protect Pharmaceutical Corporation Fundamentals Summary
PRTT fundamental statistics | |
---|---|
Market cap | US$149.37m |
Earnings (TTM) | -US$15.04k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs PRTT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PRTT income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$15.04k |
Earnings | -US$15.04k |
Last Reported Earnings
Jun 30, 2018
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did PRTT perform over the long term?
See historical performance and comparison